AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats

Brain Research

Volumn 753, Issue 1, 1997, Pages 80-85

  Yao, Hiroshi ^a,b   Ibayashi, Setsuro ^a   Nakane, Hiroshi ^a   Cai, Hong ^a   Uchimura, Hideyuki ^b   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Hizen National Mental Hospital   (Japan)

Author keywords

excitotoxicity; focal cerebral ischemia; krypton laser; photothrombosis; rose bengal; stroke

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTERY OCCLUSION; ARTICLE; BRAIN ARTERY; BRAIN INFARCTION; CONTROLLED STUDY; DOPPLER FLOWMETRY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOSIS;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL INFARCTION; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; HYPERTENSION; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; NEUROPROTECTIVE AGENTS; QUINOXALINES; RATS; RATS, INBRED SHR; RECEPTORS, AMPA;

EID: 0030947133     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01494-1     Document Type: Article

References (29)

1. Back, T., Ginsberg, M.D., Dietrich, W.D. and Watson, B.D., Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology, J. Cereb. Blood Flow Metab., 16 (1996) 202-213.
2. Barbour, B., Brew, H. and Attwell, D., Electrogenic glutamate uptake in glial cells is activated by intracellular potassium, Nature, 335 (1988) 433-435.
3. 3H]-L-glutamate release from rat hippocampal synaptosomes, Br. J. Pharmacol., 113 (1994) 339-341.
4. Buchan, A.M., Lesiuk, H., Barnes, K.A., Li, H., Huang, Z.-G., Smith, E.S. and Xue, D., AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke, 24 (Suppl. I) (1993) I-148-I-152.
5. Buchan, A.M., Xue, D., Huang, Z.-G., Smith, K.H. and Lesiuk, H., Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia, NeuroReport, 2 (1991) 473-476.
6. Bullock, R., Graham, D.I., Swanson, S. and McCulloch, J., Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat, J. Cereb. Blood Flow Metab., 14 (1994) 466-471.
7. Caner, H., Collins, J.L., Harris, S.M., Kassell, N.F. and Lee, K.S., Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor, Brain Res., 607 (1993) 354-356.
8. Chittajallu, R., Vignes, M., Dev, K.K., Barnes, J.M., Collingridge, G.L. and Henley, J.M., Regulation of glutamate release by presynaptic kainate receptors in the hippocampus, Nature, 379 (1996) 78-81.
9. Dugan, L.L., Bruno, V.M.G., Amagasu, S.M. and Giffard, R.G., Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity, J. Neurosci., 15 (1995) 4545-4555.
10. Durand, G.M., Kovalchuk, Y. and Konnerth, A., Long-term potentiation and functional synapse induction in developing hippocampus, Nature, 381 (1996) 71-75.
11. Glazier, S.S., O'Rourke, D.M., Graham, D.I. and Welsh, F.A., Induction of ischemic tolerance following brief focal ischemia in rat brain, J. Cereb. Blood Flow Metab., 14 (1994) 545-533.
12. Gill, R., Nordholm, L. and Lodge, D., The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat model of focal ischaemia model, Brain Res., 580 (1992) 35-43.
13. Heurteaux, C., Lauritzen, I., Widmann, C. and Lazdunski, M., Glutamate-induced overexpression of NMDA receptor messenger RNAs and protein triggered by activation of AMPA/kainate receptors in rat hippocampus following forebrain ischemia, Brain Res., 659 (1994) 67-74.
14. Pellegrini-Giampietro, D.E., Zukin, R.S., Bennett, M.V., Cho, S. and Pulsinelli, W.A., Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats, Proc. Natl. Acad. Sci. USA, 89 (1992) 10499-10503.
15. Prado, R., Watson, B.D., Zhao, W., Yao, H., Busto, R., Dietrich, W.D., Ginsberg, M.D., L-Arginine dose not improve cortical perfusion or histopathological outcome in spontaneously hypertensive rats subjected to distal middle cerebral artery photothrombotic occlusion, J. Cereb. Blood Flow Metab., 16 (1996) 612-622.
16. Rosenberg, P.A. and Aizenman, E., Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex, Neurosci. Lett., 103 (1989) 162-168.
17. Rump, A., Sommer, C., Gass, P., Bele, S., Meissner, D. and Kiessling, M., Editing of GluR2 RNA in the gerbil hippocampus after global cerebral ischemia, J. Cereb. Blood Flow Metab., 16 (1996) 1362-1365.
18. Sheardown, M.J., Nielsen, E.O., Hansen, A.J., Jacobsen, P. and Honoré, T., 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia, Science, 247 (1990) 571-574.
19. Shimizu-Sasamata, M., Kawasaki-Yatsugi, S., Okada, M., Sakamoto, S., Yatsugi, S., Togami, J., Hatanaka, K., Ohmori, J., Koshiya, K., Usuda, S. and Murase, K, YM90K: pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist, J. Pharmacol. Exp. Ther., 276 (1996) 84-92.
20. Siesjö, B.K. and Bengtsson, F., Calcium fluxes, calcium antagonists, and calcium related pathology in brain ischemia, hypoglycemia, and spreading depression, a unifying hypothesis, J. Cereb. Blood Flow Metab., 9 (1989) 127-140.
21. Smith, S.E. and Meldrum, B.S., Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat, Stroke, 23 (1992) 861-864.
22. Szatkowski, M., Barbour, B. and Attwell, D., Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake, Nature, 348 (1990) 443-446.
23. Takagi, K., Ginsberg, M.D., Globus, M.Y.-T., Dietrich, W.D., Martinez, E., Kraydieh, S. and Busto, R., Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology, J. Cereb. Blood Flow Metab., 13 (1993) 575-585.
24. Watson, B.D., Dietrich, W.D., Prado, R., Nakayama, H., Kanemitsu, H., Futrell, N., Yao, H., Markgraf, C.G. and Wester, P., Concepts and techniques of experimental stroke induced by cerebrovascular photothrombosis. In S.T. Ohnishi and T. Ohnishi (Eds.), Central Nervous System Trauma: Laboratory Techniques and Recent Advancement, CRC Press, Boca Raton, FL, 1995, pp. 169-194.
25. Weiss, J.H., Hartley, D.M., Koh, J. and Choi, D.W., The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity, Science, 247 (1990) 1474-1477.
26. Yao, H., Ginsberg, M.D., Watson, B.D., Prado, R., Dietrich, W.D., Kraydieh, S. and Busto, R., Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats, Stroke, 24 (1993) 864-871.
27. Yao, H., Markgraf, C.G., Dietrich, W.D., Prado, R., Watson, B.D. and Ginsberg, M.D., Glutamate antagonist MK-801 attenuates incomplete but not complete infarction in thrombotic distal middle cerebral artery occlusion in Wistar rats, Brain Res., 642 (1994) 117-122.
28. Yao, H., Ibayashi, S., Sugimori, H., Fujii, K. and Fujishima, M., Simplified model of krypton laser-induced thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats, Stroke, 27 (1996) 333-336.
29. Xue, D., Huang, Z.-G., Barnes, K., Lesiuk, H., Smith, K.E. and Buchan, A.M., Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction, J. Cereb. Blood Flow Metab., 14 (1994) 251-261.